3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Neoplasms
1
Kidney Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
Radiosurgery
24
lenvatinib
19
Radiofrequency Ablation
16
Hepatectomy
13
Sorafenib
12
Surgical Procedures, Operative
9
Radiotherapy
9
camrelizumab
7
Magnetic Resonance Spectroscopy
7
Blood Specimen Collection
7
Bevacizumab
7
sintilimab
6
apatinib
6
Immune Checkpoint Inhibitors
6
Electroporation
6
atezolizumab
5
tislelizumab
4
Yttrium-90
4
Proton Therapy
4
Oxaliplatin
4
Liver Transplantation
4
Doxorubicin
4
Control Groups
4
Cisplatin
4
Chemoembolization, Therapeutic
4
Catheter Ablation
4
spartalizumab
3
entecavir
3
X-Rays
3
Standard of Care
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Carcinoma, Hepatocellular
×
Histocompatibility Testing
×
Clear all
NCT07623265
2026-06-03
IO-MARC
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
300 enrolled